Ligand validation:4TVP

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4TVP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4TVP_NAG_H_523	29%	89%	0.238	0.896	0.24	0.39	-	-	0	0	100%	0.9333
4TVP_NAG_B_1637	27%	88%	0.255	0.906	0.25	0.41	-	-	0	0	100%	0.9333
4TVP_NAG_G_1133	26%	89%	0.283	0.926	0.24	0.39	-	-	0	0	100%	0.9333
4TVP_NAG_B_1611	15%	89%	0.235	0.799	0.23	0.41	-	-	0	0	100%	0.9333
4TVP_NAG_G_1839	15%	89%	0.304	0.87	0.25	0.4	-	-	0	0	100%	0.9333
4TVP_NAG_G_1276	15%	56%	0.333	0.899	0.43	1.26	-	2	0	0	100%	0.9333
4TVP_NAG_G_1355	14%	90%	0.287	0.839	0.23	0.37	-	-	0	0	100%	0.9333
4TVP_NAG_B_1618	6%	91%	0.378	0.821	0.21	0.35	-	-	2	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333
5FYK_NAG_B_1668	99%	72%	0.041	0.973	0.43	0.63	-	1	1	0	100%	0.9333
5FYL_NAG_G_1582	97%	55%	0.046	0.958	0.73	0.99	1	1	0	0	100%	0.9333
5UTF_NAG_B_703	57%	79%	0.151	0.926	0.46	0.4	-	-	1	0	100%	0.9333
5U7M_NAG_G_624	49%	89%	0.121	0.866	0.2	0.43	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.